Brockhaus Technologies AG

  • WKN: A2GSU4
  • ISIN: DE000A2GSU42
  • Land: Deutschland

Nachricht vom 16.08.2021 | 14:21

Brockhaus Capital Management AG: Significant increase of the pro forma forecast for fiscal year 2021

Brockhaus Capital Management AG / Key word(s): Forecast/Change in Forecast
Brockhaus Capital Management AG: Significant increase of the pro forma forecast for fiscal year 2021

16-Aug-2021 / 14:21 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Significant increase of the pro forma forecast for fiscal year 2021

Frankfurt am Main, August 16, 2021. Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, "BCM AG") significantly increases its pro forma forecast for the fiscal year 2021.

As a result of the acquisition of Bikeleasing-Service GmbH & Co. KG (together with ist affiliated companies "Bikeleasing"), BCM AG is raising its pro forma forecast significantly and now expects for fiscal year 2021 pro forma revenue of between €125m and €135m (previously between €120m and €130m) and an adjusted pro forma EBITDA of between €42m and €46m (previously approx. €34m). This corresponds to an adjusted pro forma EBITDA margin between 31% and 37% (previously between 26% and 28%).

On June 16, 2021, BCM AG published a pro forma forecast for fiscal year 2021 in connection with the signing of a purchase agreement for the acquisition of Bikeleasing, which, however, was subject to considerable uncertainty as an IFRS conversion as part of the transaction was still outstanding. In view of the fact that the conversion of financials to IFRS has progressed to an advanced stage, BCM AG updates its pro forma forecast for the fiscal year 2021 accordingly.

The forecast performance indicators are pro forma values under full consolidation of Bikeleasing. This means that earnings of the Group are presented as if the acquisition of Bikeleasing had already taken place on January 1, 2021. The pro forma forecast is subject to closing of the acquisition in the current fiscal year. There still are uncertainties regarding the IFRS conversion of Bikeleasing as well as conditions precedent to the transaction such as the successful completion of a qualifying holding procedure by the Bundesanstalt für Finanzdienstleistungsaufsicht ("BaFin") and the transaction is subject to financing. For definitions of alternative performance measures, please refer to page 73 of the 2020 Annual Report of BCM AG, which can be found at

BCM Group will publish its half-year financial report H1 2021 on August 16, 2021. The report can be found on the Company's website in the Investors - Publications section.

For investors:

Brockhaus Capital Management
Paul Göhring
Head of Investor Relations
Phone: +49 69 20 43 40 978

16-Aug-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Bio-Gate AG

Original-Research: Bio-Gate AG (von GBC AG): Kaufen

02. Dezember 2021